143 related articles for article (PubMed ID: 23458759)
1. Loss of 5-hydroxymethylcytosine and ten-eleven translocation 2 protein expression in malignant melanoma.
Gambichler T; Sand M; Skrygan M
Melanoma Res; 2013 Jun; 23(3):218-20. PubMed ID: 23458759
[TBL] [Abstract][Full Text] [Related]
2. TET2-Mediated Spatiotemporal Changes of 5-Hydroxymethylcytosine During Organogenesis in the Late Mouse Fetus.
Li X; Xie F; Jin J; Wu Y; Luo Z; Zhang F; Zhang S; Chen D; Liu A
Anat Rec (Hoboken); 2019 Jun; 302(6):954-963. PubMed ID: 30369084
[TBL] [Abstract][Full Text] [Related]
3. Values of 5mC, 5hmC, and TET2 for identifying the presence and progression of breast precancerous lesion.
Zhang Z; Jin Y; Zhang W; Chu C; Zhang K; Gao X; Zhou J; Zou L; Tang F; Wang H; Zou Q
J Clin Lab Anal; 2020 May; 34(5):e23162. PubMed ID: 31867779
[TBL] [Abstract][Full Text] [Related]
4. Loss of 5-hydroxymethylcytosine and TET2 in oral squamous cell carcinoma.
Jäwert F; Hasséus B; Kjeller G; Magnusson B; Sand L; Larsson L
Anticancer Res; 2013 Oct; 33(10):4325-8. PubMed ID: 24122999
[TBL] [Abstract][Full Text] [Related]
5. 5-Hydroxymethylcytosine: An epigenetic mark frequently deregulated in cancer.
Kroeze LI; van der Reijden BA; Jansen JH
Biochim Biophys Acta; 2015 Apr; 1855(2):144-54. PubMed ID: 25579174
[TBL] [Abstract][Full Text] [Related]
6. MYC deregulates TET1 and TET2 expression to control global DNA (hydroxy)methylation and gene expression to maintain a neoplastic phenotype in T-ALL.
Poole CJ; Lodh A; Choi JH; van Riggelen J
Epigenetics Chromatin; 2019 Jul; 12(1):41. PubMed ID: 31266538
[TBL] [Abstract][Full Text] [Related]
7. Role of ten-eleven translocation proteins and 5-hydroxymethylcytosine in hepatocellular carcinoma.
Wang P; Yan Y; Yu W; Zhang H
Cell Prolif; 2019 Jul; 52(4):e12626. PubMed ID: 31033072
[TBL] [Abstract][Full Text] [Related]
8. TET2 gene expression and 5-hydroxymethylcytosine level in multiple sclerosis peripheral blood cells.
Calabrese R; Valentini E; Ciccarone F; Guastafierro T; Bacalini MG; Ricigliano VA; Zampieri M; Annibali V; Mechelli R; Franceschi C; Salvetti M; Caiafa P
Biochim Biophys Acta; 2014 Jul; 1842(7):1130-6. PubMed ID: 24735979
[TBL] [Abstract][Full Text] [Related]
9. Tumor development is associated with decrease of TET gene expression and 5-methylcytosine hydroxylation.
Yang H; Liu Y; Bai F; Zhang JY; Ma SH; Liu J; Xu ZD; Zhu HG; Ling ZQ; Ye D; Guan KL; Xiong Y
Oncogene; 2013 Jan; 32(5):663-9. PubMed ID: 22391558
[TBL] [Abstract][Full Text] [Related]
10. Association of high 5-hydroxymethylcytosine levels with Ten Eleven Translocation 2 overexpression and inflammation in Sjögren's syndrome patients.
Lagos C; Carvajal P; Castro I; Jara D; González S; Aguilera S; Barrera MJ; Quest AFG; Bahamondes V; Molina C; Urzúa U; Hermoso MA; Leyton C; González MJ
Clin Immunol; 2018 Nov; 196():85-96. PubMed ID: 29894742
[TBL] [Abstract][Full Text] [Related]
11. Structural insight into substrate preference for TET-mediated oxidation.
Hu L; Lu J; Cheng J; Rao Q; Li Z; Hou H; Lou Z; Zhang L; Li W; Gong W; Liu M; Sun C; Yin X; Li J; Tan X; Wang P; Wang Y; Fang D; Cui Q; Yang P; He C; Jiang H; Luo C; Xu Y
Nature; 2015 Nov; 527(7576):118-22. PubMed ID: 26524525
[TBL] [Abstract][Full Text] [Related]
12. Loss of 5-hydroxymethylcytosine correlates with increasing morphologic dysplasia in melanocytic tumors.
Larson AR; Dresser KA; Zhan Q; Lezcano C; Woda BA; Yosufi B; Thompson JF; Scolyer RA; Mihm MC; Shi YG; Murphy GF; Lian CG
Mod Pathol; 2014 Jul; 27(7):936-44. PubMed ID: 24390216
[TBL] [Abstract][Full Text] [Related]
13. Dynamics of ten-eleven translocation hydroxylase family proteins and 5-hydroxymethylcytosine in oligodendrocyte differentiation.
Zhao X; Dai J; Ma Y; Mi Y; Cui D; Ju G; Macklin WB; Jin W
Glia; 2014 Jun; 62(6):914-26. PubMed ID: 24615693
[TBL] [Abstract][Full Text] [Related]
14. 5-hydroxymethylcytosine marks promoters in colon that resist DNA hypermethylation in cancer.
Uribe-Lewis S; Stark R; Carroll T; Dunning MJ; Bachman M; Ito Y; Stojic L; Halim S; Vowler SL; Lynch AG; Delatte B; de Bony EJ; Colin L; Defrance M; Krueger F; Silva AL; Ten Hoopen R; Ibrahim AE; Fuks F; Murrell A
Genome Biol; 2015 Apr; 16(1):69. PubMed ID: 25853800
[TBL] [Abstract][Full Text] [Related]
15. 5-Hydroxymethylcytosine Expression in Proliferative Nodules Arising within Congenital Nevi Allows Differentiation from Malignant Melanoma.
Pavlova O; Fraitag S; Hohl D
J Invest Dermatol; 2016 Dec; 136(12):2453-2461. PubMed ID: 27456754
[TBL] [Abstract][Full Text] [Related]
16. TET2-Dependent Hydroxymethylome Plasticity Reduces Melanoma Initiation and Progression.
Bonvin E; Radaelli E; Bizet M; Luciani F; Calonne E; Putmans P; Nittner D; Singh NK; Santagostino SF; Petit V; Larue L; Marine JC; Fuks F
Cancer Res; 2019 Feb; 79(3):482-494. PubMed ID: 30538121
[TBL] [Abstract][Full Text] [Related]
17. Ten eleven translocation enzymes and 5-hydroxymethylation in mammalian development and cancer.
Kinney SR; Pradhan S
Adv Exp Med Biol; 2013; 754():57-79. PubMed ID: 22956496
[TBL] [Abstract][Full Text] [Related]
18. Versican overexpression in cutaneous malignant melanoma.
Gambichler T; Kreuter A; Grothe S; Altmeyer P; Brockmeyer NH; Rotterdam S
Eur J Med Res; 2008 Nov; 13(11):500-4. PubMed ID: 19073385
[TBL] [Abstract][Full Text] [Related]
19. The TET2 interactors and their links to hematological malignancies.
Pan F; Weeks O; Yang FC; Xu M
IUBMB Life; 2015 Jun; 67(6):438-45. PubMed ID: 26099018
[TBL] [Abstract][Full Text] [Related]
20. Altering 5-hydroxymethylcytosine modification impacts ischemic brain injury.
Miao Z; He Y; Xin N; Sun M; Chen L; Lin L; Li J; Kong J; Jin P; Xu X
Hum Mol Genet; 2015 Oct; 24(20):5855-66. PubMed ID: 26231219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]